Skip to content ↓

Dealing with the Data Deluge

MIT Sloan Management Review study: Top-performing companies most likely to use analytics in order to make decisions
Cover of MIT Sloan Management Review, with headline "Analytics: The New Path to Value"

Top-performing companies are three times more likely than their competitors to be leading users of analytics, the science of examining raw data with the aim of making informed decisions, according to a new report released this month by MIT Sloan Management Review. To better understand how organizations are approaching analytics today, the study sampled nearly 3,000 executives and business analysts from 108 countries and 30 industries.

Based on analysis of survey results, the study clearly connects analytics to competitive differentiation and performance. Top-performing firms are five times more likely to apply analytics rather than executives’ intuition across the widest possible range of decisions. And they are two times more likely to shape future business strategies and guide day-to-day operations based on analytics.

“Interestingly, the top performers also turn out to be the organizations most focused on improving their use of analytics and data, despite the fact that they’re already ahead of the adoption curve,” said Michael S. Hopkins, editor-in-chief of MIT Sloan Management Review. “We discovered that the more managers know about analytics-driven management — and see how it can create value — the more they know that they want to know more.”

On Nov. 11 Hopkins hosted a webcast in which a virtual panel of experts discussed the report’s findings. The panel included Erik Brynjolfsson, director of the MIT Center for Digital Business, Stephen Baker, author of The Numerati, and Steve LaValle, global strategy leader for IBM’s Business Analytics and Optimization service line. The report was prepared in collaboration with the IBM Institute for Business Value.


Related Links

Related Topics

More MIT News

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story